Nature reviews urology文章索引

期刊目录筛选

期刊名：Nature reviews urology

缩写：NAT REV UROL

ISSN：1759-4812

e-ISSN：1759-4820

IF/分区：14.6/Q1

文章目录更多期刊信息

共收录本刊相关文章索引3109条

Salvage prostatectomy for recurrent disease [0.03%] 复发性前列腺癌的挽救性前列腺切除术

Gaëtan Devos,Steven Joniau Gaëtan Devos

Nature reviews. Urology. 2019 Mar;16(3):150-151. DOI:10.1038/s41585-018-0143-5 2019

Evolutionary and clinical trajectories of early-onset prostate cancer [0.03%] 早期前列腺癌的演化和临床轨迹

Conor A Bradley Conor A Bradley

Comment Nature reviews. Urology. 2019 Mar;16(3):145. DOI:10.1038/s41585-019-0144-z 2019

Hyperpolarized MRI illustrates metabolic response to therapy [0.03%] 超极化MRI展示了对治疗的代谢反应

Annette Fenner Annette Fenner

Comment Nature reviews. Urology. 2019 Mar;16(3):146-147. DOI:10.1038/s41585-018-0139-1 2019

Refining existing knowledge and management of bladder cancer [0.03%] 膀胱癌的现有知识及管理：重新思考与展望

Min Yuen Teo,Jonathan E Rosenberg Min Yuen Teo

Nature reviews. Urology. 2019 Feb;16(2):75-76. DOI:10.1038/s41585-018-0137-3 2019

ERCC2 mutations drive cisplatin sensitivity [0.03%] ERCC2基因突变驱动顺铂敏感性

Conor A Bradley Conor A Bradley

Comment Nature reviews. Urology. 2019 Feb;16(2):67. DOI:10.1038/s41585-018-0141-7 2019

Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network [0.03%] 取自MAPP研究网络的慢性盆腔疼痛综合征的见解

J Quentin Clemens,Chris Mullins,A Lenore Ackerman et al. J Quentin Clemens et al.

Urologic chronic pelvic pain syndrome (UCPPS), which encompasses interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome, is characterized by chronic pain in the pelvic region or genitalia that is of...

Review Nature reviews. Urology. 2019 Mar;16(3):187-200. DOI:10.1038/s41585-018-0135-5 2019

Practice changing for prostate cancer: a vision of the future [0.03%] 前列腺癌治疗的变革：未来的愿景

Tobias Maurer,Matthias Eiber Tobias Maurer

Nature reviews. Urology. 2019 Feb;16(2):71-72. DOI:10.1038/s41585-018-0134-6 2019

Reviving regenerative urology [0.03%] 复兴再生泌尿学

Margot S Damaser,Karl-Dietrich Sievert Margot S Damaser

Nature reviews. Urology. 2019 Mar;16(3):143-144. DOI:10.1038/s41585-018-0131-9 2019

Combination therapy for advanced and metastatic kidney cancer [0.03%] 晚期和转移性肾癌的联合疗法

Chung-Han Lee,Robert J Motzer Chung-Han Lee

Nature reviews. Urology. 2019 Feb;16(2):77-78. DOI:10.1038/s41585-018-0133-7 2019

ONECUT2 many towards AR-independence [0.03%] 迈向AR独立的一步：一次性注射的未来

Conor A Bradley Conor A Bradley

Comment Nature reviews. Urology. 2019 Feb;16(2):65. DOI:10.1038/s41585-018-0136-4 2019